Viewing StudyNCT00256698



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00256698
Status: COMPLETED
Last Update Posted: 2012-08-01
First Post: 2005-11-20

Brief Title: Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
relapse View
Hormone View
receptor View
positive View
breast View
cancer View
first View